AVEO logo

AVEO Pharmaceuticals (AVEO) Revenue

Annual Revenue

$42.30 M
+$36.28 M+602.69%

December 31, 2021


Summary


Performance

AVEO Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAVEOprofitabilitymetrics:

Quarterly Revenue

$30.45 M
+$5.14 M+20.33%

September 30, 2022


Summary


Performance

AVEO Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

Related metrics

TTM Revenue

$94.32 M
+$15.28 M+19.33%

September 30, 2022


Summary


Performance

AVEO TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAVEOprofitabilitymetrics:

AVEO Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+602.7%+100.7%+269.4%
3 y3 years+681.9%+18.4%+227.6%
5 y5 years+458.1%+559.9%+227.6%

AVEO Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high-42.0%at high-55.2%
5 y5-yearat high-85.8%at high-97.5%at high-93.7%
alltimeall time-74.3%-96.9%-77.2%-99.7%-47.1%-98.7%

AVEO Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Sep 2022
-
$30.45 M(+20.3%)
$94.32 M(+19.3%)
Jun 2022
-
$25.30 M(+21.0%)
$79.04 M(+29.0%)
Mar 2022
-
$20.92 M(+18.6%)
$61.30 M(+44.9%)
Dec 2021
$42.30 M(+602.7%)
$17.65 M(+16.3%)
$42.30 M(+65.6%)
Sep 2021
-
$15.17 M(+100.8%)
$25.54 M(+82.9%)
Jun 2021
-
$7.56 M(+293.5%)
$13.96 M(+95.1%)
Mar 2021
-
$1.92 M(+116.7%)
$7.16 M(+18.9%)
Dec 2020
$6.02 M(-79.1%)
$886.00 K(-75.4%)
$6.02 M(+2.1%)
Sep 2020
-
$3.60 M(+380.6%)
$5.90 M(-78.9%)
Jun 2020
-
$749.00 K(-4.5%)
$28.01 M(+0.2%)
Mar 2020
-
$784.00 K(+2.6%)
$27.97 M(-2.9%)
Dec 2019
$28.80 M(+432.4%)
$764.00 K(-97.0%)
$28.80 M(-2.4%)
Sep 2019
-
$25.72 M(+3558.2%)
$29.51 M(+371.2%)
Jun 2019
-
$703.00 K(-56.4%)
$6.26 M(+4.5%)
Mar 2019
-
$1.61 M(+8.6%)
$5.99 M(+10.8%)
Dec 2018
$5.41 M(-28.6%)
$1.48 M(-39.9%)
$5.41 M(+35.0%)
Sep 2018
-
$2.47 M(+469.7%)
$4.01 M(-34.9%)
Jun 2018
-
$433.00 K(-57.8%)
$6.16 M(+1.4%)
Mar 2018
-
$1.03 M(+1151.2%)
$6.07 M(-19.9%)
Dec 2017
$7.58 M(+201.4%)
$82.00 K(-98.2%)
$7.58 M(-0.6%)
Sep 2017
-
$4.61 M(+1214.5%)
$7.62 M(+90.5%)
Jun 2017
-
$351.00 K(-86.1%)
$4.00 M(+4.1%)
Mar 2017
-
$2.53 M(+1893.7%)
$3.84 M(+52.8%)
Dec 2016
$2.52 M(-86.8%)
$127.00 K(-87.2%)
$2.52 M(-58.0%)
Sep 2016
-
$992.00 K(+414.0%)
$5.99 M(-70.3%)
Jun 2016
-
$193.00 K(-84.0%)
$20.15 M(+0.3%)
Mar 2016
-
$1.20 M(-66.6%)
$20.09 M(+5.6%)
Dec 2015
$19.02 M
$3.60 M(-76.3%)
$19.02 M(+22.4%)
DateAnnualQuarterlyTTM
Sep 2015
-
$15.16 M(>+9900.0%)
$15.54 M(+1136.4%)
Jun 2015
-
$134.00 K(0.0%)
$1.26 M(-57.7%)
Mar 2015
-
$134.00 K(+15.5%)
$2.97 M(-83.6%)
Dec 2014
$18.12 M(+1301.6%)
$116.00 K(-86.7%)
$18.12 M(-1.1%)
Sep 2014
-
$873.00 K(-52.7%)
$18.33 M(+3.1%)
Jun 2014
-
$1.85 M(-87.9%)
$17.78 M(+9.4%)
Mar 2014
-
$15.29 M(+4633.4%)
$16.26 M(+1157.5%)
Dec 2013
$1.29 M(-93.3%)
$323.00 K(0.0%)
$1.29 M(-92.2%)
Sep 2013
-
$323.00 K(-0.3%)
$16.50 M(-4.0%)
Jun 2013
-
$324.00 K(+0.3%)
$17.20 M(-8.3%)
Mar 2013
-
$323.00 K(-97.9%)
$18.75 M(-2.8%)
Dec 2012
$19.29 M(-88.3%)
$15.53 M(+1425.6%)
$19.29 M(+297.6%)
Sep 2012
-
$1.02 M(-45.8%)
$4.85 M(-34.6%)
Jun 2012
-
$1.88 M(+118.3%)
$7.42 M(-76.9%)
Mar 2012
-
$860.00 K(-21.5%)
$32.09 M(-80.5%)
Dec 2011
$164.85 M(+268.9%)
$1.10 M(-69.4%)
$164.85 M(-6.2%)
Sep 2011
-
$3.58 M(-86.5%)
$175.71 M(-1.5%)
Jun 2011
-
$26.55 M(-80.1%)
$178.35 M(+6.5%)
Mar 2011
-
$133.61 M(+1017.5%)
$167.41 M(+274.7%)
Dec 2010
$44.68 M(+115.7%)
$11.96 M(+92.2%)
$44.68 M(+15.3%)
Sep 2010
-
$6.22 M(-60.2%)
$38.76 M(+0.8%)
Jun 2010
-
$15.62 M(+43.6%)
$38.46 M(+37.7%)
Mar 2010
-
$10.88 M(+80.3%)
$27.93 M(+34.8%)
Dec 2009
$20.72 M(+5.4%)
$6.04 M(+2.0%)
$20.72 M(+7.4%)
Sep 2009
-
$5.92 M(+16.1%)
$19.29 M(+44.2%)
Jun 2009
-
$5.10 M(+38.9%)
$13.37 M(+61.6%)
Mar 2009
-
$3.67 M(-20.4%)
$8.28 M(+79.6%)
Dec 2008
$19.66 M(+78.2%)
$4.61 M
$4.61 M
Dec 2007
$11.03 M
-
-

FAQ

  • What is AVEO Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals annual revenue year-on-year change?
  • What is AVEO Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals quarterly revenue year-on-year change?
  • What is AVEO Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals TTM revenue year-on-year change?

What is AVEO Pharmaceuticals annual revenue?

The current annual revenue of AVEO is $42.30 M

What is the all time high annual revenue for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high annual revenue is $164.85 M

What is AVEO Pharmaceuticals annual revenue year-on-year change?

Over the past year, AVEO annual revenue has changed by +$36.28 M (+602.69%)

What is AVEO Pharmaceuticals quarterly revenue?

The current quarterly revenue of AVEO is $30.45 M

What is the all time high quarterly revenue for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high quarterly revenue is $133.61 M

What is AVEO Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, AVEO quarterly revenue has changed by +$15.28 M (+100.68%)

What is AVEO Pharmaceuticals TTM revenue?

The current TTM revenue of AVEO is $94.32 M

What is the all time high TTM revenue for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high TTM revenue is $178.35 M

What is AVEO Pharmaceuticals TTM revenue year-on-year change?

Over the past year, AVEO TTM revenue has changed by +$68.78 M (+269.37%)